Diaceutics PLC 7DC.F Stock
Diaceutics PLC Price Chart
Diaceutics PLC 7DC.F Financial and Trading Overview
Diaceutics PLC stock price | 1.19 EUR |
Previous Close | 0.98 EUR |
Open | 0.98 EUR |
Bid | 0.98 EUR x 0 |
Ask | 1.05 EUR x 0 |
Day's Range | 0.98 - 0.98 EUR |
52 Week Range | 0.82 - 1.39 EUR |
Volume | 3K EUR |
Avg. Volume | 71 EUR |
Market Cap | 84.88M EUR |
Beta (5Y Monthly) | 0.324964 |
PE Ratio (TTM) | 98.00001 |
EPS (TTM) | 0 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
7DC.F Valuation Measures
Enterprise Value | 64.07M EUR |
Trailing P/E | 98.00001 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 4.3520813 |
Price/Book (mrq) | 1.9405941 |
Enterprise Value/Revenue | 3.285 |
Enterprise Value/EBITDA | 30.861 |
Trading Information
Diaceutics PLC Stock Price History
Beta (5Y Monthly) | 0.324964 |
52-Week Change | -19.0082% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.39 EUR |
52 Week Low | 0.82 EUR |
50-Day Moving Average | 1.06 EUR |
200-Day Moving Average | 1 EUR |
7DC.F Share Statistics
Avg. Volume (3 month) | 71 EUR |
Avg. Daily Volume (10-Days) | 300 EUR |
Shares Outstanding | 84.47M |
Float | 46.53M |
Short Ratio | N/A |
% Held by Insiders | 46.78% |
% Held by Institutions | 47.41% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 3.71% |
Operating Margin (ttm) | 2.94% |
Gross Margin | 85.83% |
EBITDA Margin | 10.64% |
Management Effectiveness
Return on Assets (ttm) | 0.77% |
Return on Equity (ttm) | 1.74% |
Income Statement
Revenue (ttm) | 19.5M EUR |
Revenue Per Share (ttm) | 0.23 EUR |
Quarterly Revenue Growth (yoy) | 50.10% |
Gross Profit (ttm) | 16.74M EUR |
EBITDA | 2.08M EUR |
Net Income Avi to Common (ttm) | 724K EUR |
Diluted EPS (ttm) | 0.01 |
Quarterly Earnings Growth (yoy) | 66.40% |
Balance Sheet
Total Cash (mrq) | 19.84M EUR |
Total Cash Per Share (mrq) | 0.24 EUR |
Total Debt (mrq) | 1.33M EUR |
Total Debt/Equity (mrq) | 3.13 EUR |
Current Ratio (mrq) | 8.235 |
Book Value Per Share (mrq) | 0.505 |
Cash Flow Statement
Operating Cash Flow (ttm) | 5.1M EUR |
Levered Free Cash Flow (ttm) | -354625 EUR |
Profile of Diaceutics PLC
Country | Germany |
State | N/A |
City | Belfast |
Address | Building Two |
ZIP | BT9 6GW |
Phone | N/A |
Website | https://www.diaceutics.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 151 |
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Q&A For Diaceutics PLC Stock
What is a current 7DC.F stock price?
Diaceutics PLC 7DC.F stock price today per share is 1.19 EUR.
How to purchase Diaceutics PLC stock?
You can buy 7DC.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Diaceutics PLC?
The stock symbol or ticker of Diaceutics PLC is 7DC.F.
Which industry does the Diaceutics PLC company belong to?
The Diaceutics PLC industry is Diagnostics & Research.
How many shares does Diaceutics PLC have in circulation?
The max supply of Diaceutics PLC shares is 86.62M.
What is Diaceutics PLC Price to Earnings Ratio (PE Ratio)?
Diaceutics PLC PE Ratio is now.
What was Diaceutics PLC earnings per share over the trailing 12 months (TTM)?
Diaceutics PLC EPS is 0 EUR over the trailing 12 months.
Which sector does the Diaceutics PLC company belong to?
The Diaceutics PLC sector is Healthcare.